Browsing by Author "Elisaf, Moses S."
Now showing items 1-15 of 15
-
Article
Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?
Liberopoulos, E. N.; Karabina, S. A.; Tselepis, A.; Bairaktari, Eleni Th; Nikolaides, C.; Pavlidis, Nicholas; Elisaf, Moses S. (2002)Background: Tamoxifen has favorable effects on the serum lipid profile. It has been suggested that the apolipoprotein (Apo) E phenotype can influence serum lipid parameters; the ApoE allele 4 (ApoE4) is associated with ...
-
Article
The beneficial effect of tamoxifen on serum lipoprotein-a levels: An additional anti-atherogenic property
Elisaf, Moses S.; Bairaktari, Eleni Th; Nikolaides, C.; Fountzilas, George; Tzallas, C. S.; Siamopoulos, K. C.; Tsolas, O.; Pavlidis, Nicholas (1996)It has recently been suggested that increased lipoprotein (a) levels are an independent risk factor for coronary heart disease. It has also been reported that tamoxifen can induce changes in blood lipid values. In this ...
-
Article
Clinical picture: Acquired icthyosis: A paraneoplastic skin manifestation of Hodgkin's disease
Rizos, E.; Milionis, Haralampos J.; Pavlidis, Nicholas; Elisaf, Moses S. (2002)
-
Article
Do LH-RH analogues induce effects similar to tamoxifen on serum lipid parameters in premenopausal women with breast cancer? A prospective study
Elisaf, Moses S.; Bairaktari, Eleni Th; Nikolaides, C.; Fountzilas, George; Tzallas, C. S.; Tsolas, O.; Siamopoulos, K. C.; Pavlidis, Nicholas (1998)Background and Aim: As a continuation of our investigational program we carried out the present study to evaluate and compare the impact of LH-RH analogues and tamoxifen on serum lipid parameters in premenopausal women ...
-
Article
Effect of letrozole on the lipid profile in postmenopausal women with breast cancer
Elisaf, Moses S.; Bairaktari, Eleni Th; Nikolaides, C.; Kakaidi, B.; Tzallas, C. S.; Katsaraki, A.; Pavlidis, Nicholas (2001)Hormonal therapy plays a central role in the overall treatment of breast cancer. Aromatase inhibitors can inhibit the aromatase enzyme system resulting in a reduction of oestrogens. Letrozole is a non-steroidal aromatase ...
-
Article
The effect of tamoxifen therapy on serum apolipoprotein A-I level is modified by the apolipoprotein E phenotype
Liberopoulos, E. N.; Pavlidis, Nicholas; Elisaf, Moses S. (2001)
-
Article
Effects of hormonal treatment on lipids in patients with cancer
Filippatos, T. D.; Liberopoulos, E. N.; Pavlidis, Nicholas; Elisaf, Moses S.; Mikhailidis, Dimitri P. (2009)Patients with malignant disease may need hormonal therapy as primary or adjuvant treatment or for palliation. Oestrogens usually decrease serum levels of total cholesterol (TC) and low density lipoprotein cholesterol ...
-
Article
The influence of tamoxifen on serum triglycerides
Elisaf, Moses S.; Bairaktari, Eleni Th; Pavlidis, Nicholas (2000)
-
Article
Metabolic syndrome and its components as predictors of ischemic stroke in type 2 diabetic patients
Protopsaltis, I. D.; Korantzopoulos, Panagiotis; Milionis, Haralampos J.; Koutsovasilis, Anastasios; Nikolopoulos, Georgios K.; Dimou, Eftihia; Kokkoris, Stelios; Brestas, Paris; Elisaf, Moses S.; Melidonis, Andreas (2008)BACKGROUND AND PURPOSE - The available data regarding the association between metabolic syndrome (MS) or MS components and ischemic stroke in type 2 diabetics are limited and inconsistent. This study aimed to investigate ...
-
Article
Persistent erythema multiforme in a patient with extrahepatic cholangiocarcinoma
Tzovaras, V.; Liberopoulos, E. N.; Zioga, A.; Pavlidis, Nicholas; Elisaf, Moses S. (2008)Presented in this report is a 66-year-old male with a widespread persistent erythema multiforme mostly atypical in appearance, which was detected well before the diagnosis of underlying extrahepatic cholangiocarcinoma. The ...
-
Article
Primary lymphoma of the pericardium: Report on a 'cured' case and review of the literature
Pavlidis, Nicholas; Elisaf, Moses S.; Bai, M. C.; Ch, F. Tolis; Papadimitriou, C. (1994)This report describes a 62-year-old man with a primary diffuse, immunohistochemically proven B-cell lymphoma of large noncleaved cell (centroblastic) type of the pericardium. The patient responded completely to systemic ...
-
Article
Re: The influence of tamoxifen on serum triglycerides
Elisaf, Moses S.; Bairaktari, Eleni Th; Pavlidis, Nicholas (2000)
-
Article
Serum anion gap in multiple myeloma patients
Elisaf, Moses S.; Siamopoulos, K. C.; Bourantas, C. L.; Papagalanis, N.; Pavlidis, Nicholas (1992)The aim of this study was, first, to reconfirm the low serum anion gap (SAG) in multiple myeloma patients and, second, to propose the possible pathophysiologic mechanisms involved. We studied 20 patients with IgG multiple ...
-
Article
Successful treatment of human immunodeficiency virus-related castleman's disease: A case report and literature review
Liberopoulos, E. N.; Ch, F. Tolis; Bai, M. C.; Efremidis, S.; Pavlidis, Nicholas; Elisaf, Moses S. (2003)Multicentric Castleman's disease is increasingly recognized as an aggressive illness with a rapidly fatal outcome in human immunodeficiency virus (HIV)-infected patients. In the absence of optimal therapy, various therapeutic ...
-
Article
Tamoxifen-induced severe hypertriglyceridemia and pancreatitis
Elisaf, Moses S.; Nakou, K.; Liamis, G.; Pavlidis, Nicholas (2000)Tamoxifen exhibits favorable effects on the lipid and lipoprotein profile since it decreases the total and LDL cholesterol levels as well as the Lp(a) levels. Additionally, a small increase in serum triglycerides is commonly ...